Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation

British Journal of Cancer

Volumn 103, Issue 7, 2010, Pages 1057-1065

  Hiraoka, N ^a   Ino, Y ^a   Sekine, S ^a   Tsuda, H ^b   Shimada, K ^b   Kosuge, T ^c   Zavada, J ^b   Yoshida, M ^b   Yamada, K ^b   Koyama, T ^b   Kanai, Y ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

hypoxia; interobserver reproducibility; necrosis; pancreatic cancer; prognostic factor

Indexed keywords

CARBONATE DEHYDRATASE IX; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; TUMOR ANTIGEN;

ADULT; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NERVE CELL; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TUMOR NECROSIS; CELL HYPOXIA; EVALUATION STUDY; METABOLISM; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; REPRODUCIBILITY;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, PANCREATIC DUCTAL; CELL HYPOXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 77957231071     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605854     Document Type: Review

References (37)

1. Adsay NV, Basturk O, Bonnett M, Kilinc N, Andea AA, Feng J, Che M, Aulicino MR, Levi E, Cheng JD (2005) A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol 29: 724-733 (Pubitemid 40734422)
2. Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-192
3. Center for Cancer Control and Information Services, National Cancer Center Japan (2009) Cancer Statistics in Japan
4. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxiaregulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19: 3660-3668 (Pubitemid 32786278)
5. Couvelard A, OToole D, Leek R, Turley H, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F (2005) Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 46: 668-676 (Pubitemid 40834826)
6. Fleiss JL (1971) Measuring nominal scale agreement among many rates. Pshycol Bull 76: 378-382
7. Gilchrist KW, Gray R, Fowble B, Tormey DC, Taylor SGt (1993) Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. J Clin Oncol 11: 1929-1935 (Pubitemid 23304618)
8. Grothey A, Galanis E (2009) Targeting angiogenesis: progress with anti- VEGF treatment with large molecules. Nat Rev Clin Oncol 6: 507-518
9. Harris AL (2002) Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47
10. Hruban RH, Pitman MB, Klimstra DS (2007) Ductal adenocarcinoma. In AFIP Atlas of Tumor Pathology. Tumors of the Pancreas, Hruban RH, Pitman MB, Klimstra DS (eds) 4th edn, pp 111- 164. ARP Press: Washington, DC
11. Japan Pancreas Society (2003) Classification of Pancreatic Cancer. 2nd English edn, Kanehara: Tokyo, Japan
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249
13. Kitada T, Seki S, Sakaguchi H, Sawada T, Hirakawa K, Wakasa K (2003) Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma. Histopathology 43: 550-555 (Pubitemid 38002343)
14. Klöppel G, Adler G, Hruban RH, Kern SE, Longnecker DS, Partanen TJ (2000) Ductal adenocarcinoma of the pancreas. In World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Digestive System, Hamilton SR, Aaltonen LA (eds), pp 221 -230. IARC Press: Lyon
15. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174
16. Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237: 74-85
17. Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Klöppel G (2000) The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol 191: 154-161 (Pubitemid 30394893)
18. Mitsunaga S, Hasebe T, Iwasaki M, Kinoshita T, Ochiai A, Shimizu N (2005) Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci 96: 858-865 (Pubitemid 43056123)
19. Mitsunaga S, Hasebe T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Nakagohri T, Ochiai A (2007) Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol 31: 1636-1644 (Pubitemid 350287561)
20. Nakatsura T, Hasebe T, Tsubono Y, Ryu M, Kinoshita T, Kawano N, Konishi M, Kosuge T, Kanai Y, Mukai K (1997) Histological prognostic parameters for adenocarcinoma of the pancreatic head. Proposal for a scoring system for prediction of outcome. J Hep Bil Pancr Surg 4: 441-448 (Pubitemid 127722719)
21. Ord JJ, Agrawal S, Thamboo TP, Roberts I, Campo L, Turley H, Han C, Fawcett DW, Kulkarni RP, Cranston D, Harris AL, Ord JJ, Agrawal S, Thamboo TP, Roberts I, Campo L, Turley H, Han C, Fawcett DW, Kulkarni RP, Cranston D, Harris AL (2007) An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer. J Urol 178: 677-682 (Pubitemid 47030492)
22. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J (1992) A novel quasi-viral agent, MaTu, is a two-component system. Virology 187: 620-626
23. Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, OReilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J (2009) Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27: 5660-5669
24. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247: 456-462
25. Semenza GL (2006) Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 10: 267-280
26. Semenza GL (2009) HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr Pharm Des 15: 3839-3843
27. Sessa C, Guibal A, Del Conte G, Ruegg C (2008) Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? Nat Clin Pract Oncol 5: 378-391 (Pubitemid 351958963)
28. Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N (2006) Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma. Pancreas 33: 233-239 (Pubitemid 44470137)
29. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4: 567-579
30. Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, Huang C, Sun H-C, Qiu Z-J, Liu J, Sun J, Jiang T, Huang K-J, Yao M, Huang C (2007) Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 30: 1359-1367
31. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, Sano T, Kosuge T, Nimura Y, Kanai Y, Hiraoka N (2007) Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 13: 187-196 (Pubitemid 46121868)
32. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, Araki H, Matsui Y, Imamura A, Kwon AH, Kamiyama Y (2003) Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 26: 243-249 (Pubitemid 36384156)
33. Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211: 447-458 (Pubitemid 20138186)
34. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26: 225-239 (Pubitemid 47101660)
35. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2005) UICC TNM Atlas 5th edn, Springer: New York, NY
36. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-731; discussion 731-733
37. Zavada J, Zavadova Z, Pastorek J, Biesova Z, Jezek J, Velek J (2000) Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion. Br J Cancer 82: 1808-1813 (Pubitemid 30307393)